Related by context. All words. (Click for frequent words.) 74 LRRK2 mutations 71 Genetic variants 71 APOE genotype 69 nondemented 69 nonmelanoma skin cancers 69 RET PTC rearrangements 69 hereditary predisposition 68 autosomal dominant inheritance 68 brain lesions 68 EBV infection 68 sCJD 68 susceptibility loci 68 genetic variants associated 68 #q# deletion 67 familial pancreatic cancer 67 sporadic ALS 67 CP CPPS 67 familial clustering 67 inherited mutations 67 APOE ε4 67 PCNSL 67 neurocognitive deficits 67 multifactorial disease 67 pilocytic astrocytomas 67 de novo mutations 67 inflammatory polyarthritis 67 MYCN amplification 67 TCF#L# gene 67 osteosarcomas 67 ADPKD 67 KCNH2 67 MGUS 67 neurological abnormalities 67 euthymic patients 66 biochemical abnormalities 66 TGFBR1 * 6A 66 genetic polymorphisms 66 narcolepsy cataplexy 66 autoimmune thyroiditis 66 genetic loci 66 germline mutations 66 basal cell nevus syndrome 66 diabetes mellitus DM 66 aortic atherosclerosis 66 autonomic dysfunction 66 Prostatitis 66 autopsied brains 66 squamous cell lung cancer 66 subclinical hyperthyroidism 66 Leydig cell 66 K ras mutations 66 arterial calcification 66 APOE e4 66 susceptibility gene 66 ataxias 65 postoperative delirium 65 familial aggregation 65 familial ALS 65 carotid plaques 65 penetrance 65 Genetic predisposition 65 nonhereditary 65 Colon polyps 65 DQB1 * 65 seropositivity 65 neurocognitive impairment 65 atypical hyperplasia 65 chorioamnionitis 65 white matter hyperintensities 65 T1DM 65 tumor histology 65 #q#.# deletion syndrome 65 susceptibility locus 65 Cognitive impairment 65 latent celiac disease 65 Neurofibromatosis type 65 molecular abnormalities 65 CC genotype 65 underlying pathophysiology 65 motor neuron degeneration 65 CSF biomarkers 65 KRAS oncogene 65 IgA deficiency 65 colorectal adenoma 65 leptin deficiency 65 olfactory dysfunction 65 microscopic colitis 65 incidentalomas 65 monogenic 65 LRRK2 gene 65 neuropathologic 65 chromosomal alterations 65 low ptau levels 65 ALI ARDS 65 Hashimoto thyroiditis 65 Brugada syndrome 64 BRCA1 mutations 64 Excessive daytime sleepiness 64 progressive neurodegenerative disorder 64 elevated triglyceride levels 64 thiopurine 64 comorbid depression 64 HER2 positive cancers 64 missense mutations 64 JAK mutations 64 neurosensory 64 ApoE4 gene 64 HNPCC 64 breast endometrial 64 advanced adenomas 64 spontaneous mutations 64 idiopathic PAH 64 progressive neurodegenerative 64 IDH1 mutation 64 hypovitaminosis D 64 obstructive coronary artery 64 fronto temporal dementia 64 untreated celiac disease 64 hyperinsulinism 64 carotid atherosclerosis 64 HIV HCV coinfected 64 oral squamous cell 64 Sjögren syndrome 64 neurologic complications 64 chlamydial infection 64 NNRTI resistance 64 CALHM1 64 LRRK2 mutation 64 subclinical disease 64 artery stenosis 64 atypical neuroleptics 64 HLA DRB1 64 neuropsychological impairments 64 mitochondrial disorders 64 neurologic symptoms 64 precancerous condition 64 proband 64 chromosomal rearrangement 64 microsatellite instability 64 cardioembolic stroke 64 HSV1 64 prostate cancer CaP 64 nonalcoholic steatohepatitis NASH 64 proliferative diabetic retinopathy 64 inherited genetic mutations 64 colorectal neoplasia 64 hypermethylated 64 genomewide association studies 64 lichen planus 64 activated microglia 64 Li Fraumeni 64 varicella infection 64 autoimmune thyroid 63 ApoE gene 63 VADT 63 Univariate analysis 63 monozygotic twin 63 neoplasias 63 microbleeds 63 APOE e4 gene 63 meningiomas 63 mild cognitive impairments 63 highly heritable 63 elevated CRP 63 pathogenic mutations 63 BRCA1 mutation carriers 63 SCN5A 63 telomere lengths 63 comorbid disorders 63 leiomyomas 63 coinfection 63 BRCA1 BRCA2 63 Alzheimer Disease AD 63 C. pneumoniae 63 neurologic disorders 63 microdeletion 63 alexithymia 63 HER2 amplification 63 thyrotropin levels 63 cranial irradiation 63 etiologic 63 seminomas 63 cytogenic 63 MMSE scores 63 gonococcal 63 POAG 63 microdeletions 63 clinicopathological 63 advanced neoplasia 63 gene polymorphism 63 gastroesophageal reflux GERD 63 Multivariate analyzes 63 childhood leukemias 63 relapsed ALL 63 neuroblastomas 63 Synovial sarcoma 63 NOMID 63 cerebral microbleeds 63 nonmelanoma 63 perimenopausal women 63 atopic disorders 63 herpesviruses 63 LQTS 63 neurodevelopmental impairment 63 parkinsonism 63 mtDNA mutations 63 adenomatous 63 nonseminoma 63 Heavy menstrual bleeding 63 hamartomas 63 G6PD deficiency 63 endometrial hyperplasia 63 renal cell carcinomas 63 genetic determinants 63 Vitamin B# deficiency 63 serous ovarian cancer 63 EoE 63 hepatocellular carcinomas 63 autistic traits 63 GSTT1 63 serum BDNF 63 PTPN# 63 biologic pathways 63 testicular tumors 63 ductal breast cancer 63 choroidal vasculopathy 63 neurocognitive dysfunction 63 chromosomal anomalies 63 SE alleles 63 cytogenetic abnormalities 63 dominantly inherited 63 hyperacute 63 Aortic stenosis 63 chest radiographs 63 TP# mutation 63 acute lymphoid leukemia 63 RLS sufferers 63 glioblastoma tumors 63 lobular breast cancer 63 proliferative retinopathy 63 Subgroup analyzes 63 #q#.# [001] 63 Hp2 2 63 predisposing factor 63 spirometric 63 MTHFD1L gene 63 Chronic lymphocytic leukemia 63 parkinsonian 63 chronic prostatitis 63 SHANK3 63 Parkinsonian Syndromes 63 heterozygotes 63 BMPR2 63 PsA 63 osteoporotic vertebral compression fractures 63 anatomical abnormalities 63 Li Fraumeni syndrome 63 familial adenomatous polyposis 63 Chronic pancreatitis 63 murine models 62 retrovirus XMRV 62 normal karyotype 62 UGT#A# * 62 prostate carcinogenesis 62 HbF 62 type2 diabetes 62 APOE4 62 G#S mutation 62 subclinical hypothyroidism 62 FTLD 62 HER2 expression 62 ovarian hormones 62 atypical parkinsonism 62 stratifying patients 62 progranulin mutations 62 untreated OSA 62 EGFR mutations 62 subclinical atherosclerosis 62 neuroblastoma tumors 62 malignant lymphoma 62 diabetic kidney 62 non affective psychosis 62 fluoroquinolone resistance 62 liver metastasis 62 urologic diseases 62 Genetic mutation 62 silent myocardial ischemia 62 neurological disorder affecting 62 overt hypothyroidism 62 medically refractory 62 malignant neoplasm 62 KIBRA 62 lymphomas leukemias 62 Wwox 62 IPAH 62 invasive lobular 62 ABCB1 62 chromosomal aberrations 62 somatic mutations 62 intestinal polyps 62 gene APOE 62 carcinoid 62 gastric carcinoma 62 obstructive coronary 62 Epidemiologic studies 62 PTEN mutations 62 autosomal dominant polycystic kidney 62 TT genotype 62 enteroviral infection 62 hyperplastic 62 enterovirus infection 62 recurrent ischemic stroke 62 advanced adenoma 62 dopaminergic therapy 62 mutated K ras 62 Inflammatory bowel diseases 62 angiographically 62 Parkinson Disease PD 62 Genetic variations 62 pharmacologic treatments 62 HNSCC 62 antiphospholipid antibodies 62 C. trachomatis 62 mammographically 62 mitochondrial mutations 62 hematopoietic cancers 62 noncardiac 62 comorbid anxiety 62 ANCA associated 62 bronchopulmonary dysplasia BPD 62 SRBD 62 Medullary thyroid cancer 62 FGFR2 gene 62 coronary calcification 62 VaD 62 renal cysts 62 chronic hepatitis cirrhosis 62 thrombocytopenic 62 urothelial cancer 62 S. maltophilia 62 hippocampal function 62 unprovoked seizures 62 intracranial stenosis 62 demyelinating 62 BRCA2 carriers 62 urolithiasis 62 dyskeratosis congenita 62 immunocompetent 62 Legg Calvé Perthes disease 62 affective psychosis 62 MYH9 62 nulliparous women 62 atypical ductal hyperplasia 62 thyroid carcinoma 62 androgen deficiency 62 p# mutations 62 genomewide 62 idiopathic pulmonary arterial hypertension 62 airway hyperresponsiveness 62 Chlamydia trachomatis infection 62 GIST tumors 62 alpha1 antitrypsin deficiency 62 GH deficiency 62 orchitis 62 MSH2 62 H. pylori infections 62 mGluR2 NAM 62 degenerative neurological diseases 62 Multivariate analysis 62 hippocampal volumes 62 infarcts 62 polymorphic ventricular tachycardia 62 aMCI precursor 62 oesophageal adenocarcinoma 62 systemic amyloidosis 62 clefting 62 pancreatic endocrine 62 heritable variation 61 genomic deletions 61 myelogenous leukemia 61 pulmonary metastases 61 neuro developmental disorders 61 MYH9 gene 61 causal variants 61 myopathies 61 diagnostic biomarker 61 affective psychoses 61 hormone receptor negative 61 Squamous 61 XLHED 61 hypokalemia hypomagnesemia 61 amyloid deposition 61 neurologic disorder 61 inflammatory biomarkers 61 carcinoids 61 LHON 61 gene MECP2 61 smoldering myeloma 61 Longitudinal studies 61 intact parathyroid hormone 61 Observational studies 61 FASPS 61 sporadic Creutzfeldt Jakob 61 prolonged QT interval 61 Leukemias 61 impaired insulin secretion 61 gene polymorphisms 61 impaired glucose metabolism 61 BRCA mutation carriers 61 poorer prognosis 61 CDH1 61 comorbid illnesses 61 testicular germ cell 61 primary aldosteronism 61 amyloid pathology 61 extrapyramidal symptoms 61 vestibular schwannomas 61 amyloid plaque formation 61 hypogonadotropic hypogonadism 61 Singh Manoux 61 C1q 61 Boston DbTechNo Results 61 chromosome aberrations 61 epigenetic changes 61 albumin excretion 61 renal carcinoma 61 knee osteoarthritis OA 61 subsyndromal 61 HBeAg negative 61 Subgroup analysis 61 aneuploidies 61 node metastases 61 migraineurs 61 FXTAS 61 precancerous tumors 61 systolic dysfunction 61 leukoencephalopathy 61 AGILECT R 61 neuritic 61 methylation patterns 61 Relapsing remitting MS 61 Lung transplantation 61 habitual snoring 61 myeloproliferative neoplasms MPNs 61 Hurthle cell 61 bronchogenic carcinoma 61 genetic locus 61 chronic obstructive airway 61 syndromal 61 GBM tumors 61 Nicotine dependence 61 overactive bladder symptoms 61 cryptogenic 61 distinct subtypes 61 curable cancers 61 monoclonal gammopathy 61 chlamydial infections 61 PARP inhibition 61 ventricular enlargement 61 GSTM1 61 etiologic factors 61 carotid stenosis 61 NKX2 61 HER2 positivity 61 bivariate analyzes 61 syndromic 61 impaired cognition 61 underwent coronary angiography 61 Becker muscular dystrophy 61 KRAS mutations 61 temporal arteritis 61 allelic variants 61 colorectal neoplasms 61 adiponectin levels 61 polymyalgia rheumatica 61 HLA DR4 61 HGPS 61 DNA methylation patterns 61 abnormal Pap smear 61 gastric adenocarcinoma 61 OSAHS 61 adenomatous polyps 61 ductal adenocarcinoma 61 gastrointestinal dysfunction 61 pancreatic adenocarcinoma 61 haematologic 61 MLH1 61 SGPT 61 perfusion defects 61 NF1 61 motor neuron diseases 61 autistic regression 61 asymptomatic carriers 61 underdiagnosis 61 GG genotype 61 NP CRNs 61 reflux disease 61 neuropsychiatric symptoms 61 enteroviruses 61 endometrial cancers 61 prenatal exposures 61 diagnosing ADHD 61 leukaemias 61 clinically detectable 61 cortical atrophy 61 LV dysfunction 61 prognostic markers 61 prognostic biomarkers 61 chromosomal anomaly 61 chronic autoimmune disorder 61 bullous 61 nodal metastasis 61 urate levels 61 gene locus 61 bronchopulmonary dysplasia 61 M. catarrhalis 61 acute aortic dissection 61 lymphoid tumors 61 recurrent miscarriage 61 nonmetastatic 61 thyroid dysfunction 61 scintigraphic 61 cerebral atrophy 61 SCN1A 61 T1D 61 pathological hallmark 61 rheumatic disorders 61 transgenic rats 61 synovial fibroblasts 61 T2DM 61 hyperplastic polyps 61 cognitively normal 61 metastatic neuroendocrine tumors 61 generalized epilepsy 61 antiphospholipid syndrome 61 obstructive lung 61 Alequel 61 skeletal metastases 61 shorter telomere length 61 radiographic findings 61 rheumatologic 61 homozygotes 61 paraganglioma 61 Magnesium deficiency 60 nonischemic 60 LVNC 60 chromosome translocations 60 arteriography 60 prostate adenocarcinoma 60 causative genes 60 CTEPH 60 valvular heart disease 60 essential thrombocythemia 60 CARDIA study 60 circadian rhythm disorders 60 serum urate levels 60 lipodystrophy syndrome 60 Bacterial vaginosis 60 precancerous cervical 60 Safinamide 60 Lewy bodies DLB 60 vascular dysfunction 60 astrocytomas 60 pyridostigmine 60 APOE e4 allele 60 Chlamydia pneumoniae 60 bullous pemphigoid 60 abnormal glucose metabolism 60 herpes simplex encephalitis 60 gene APOE4 60 atrophic gastritis 60 mesotheliomas 60 carotid plaque 60 pentoxifylline 60 pathophysiological mechanisms 60 chromosome #p#.# 60 precancerous polyp 60 prognostic indicators 60 polycystic ovary syndrome PCOS 60 Epidemiological studies 60 Alzheimer disease vascular dementia 60 juvenile idiopathic arthritis JIA 60 MTHFR 60 basal cell carcinomas 60 neuro developmental disorder 60 apoE4 60 pre malignant lesions 60 intensive statin therapy 60 lipid abnormalities 60 familial polyposis 60 genomic alterations 60 cerebral vasospasm 60 HeFH 60 GSTM1 gene 60 abnormal moles 60 imatinib resistance 60 phenothiazines 60 SORL1 gene 60 serologic testing 60 gallstone disease 60 B7 H3 60 aminotransferase 60 impair fertility 60 transgenic mouse models 60 invasive ductal breast cancer 60 brain infarcts 60 FGFs 60 Adenomas 60 selenium supplementation 60 metabolic abnormalities 60 nondiabetics 60 FDG PET scans 60 persistent pulmonary hypertension 60 XMRV infection 60 CFH gene 60 histopathologic diagnosis 60 fetal malformations 60 lupus scleroderma 60 pathogenic mechanisms 60 faulty BRCA genes 60 monozygotic twins 60 nonmelanoma skin cancer 60 Parkinson disease PD 60 hereditary hemochromatosis 60 WDR# 60 subclinical 60 chronic myeloid 60 poor metabolizers 60 PAOD 60 metaplasia 60 Papillary 60 prion infection 60 multi factorial disease 60 juvenile idiopathic arthritis 60 microcephalin 60 ovarian endometrial 60 Peutz Jeghers syndrome 60 presymptomatic 60 lobular cancer 60 apolipoprotein E APOE 60 GISTs 60 beta1 integrin 60 Waldenstrom macroglobulinemia 60 Hip dysplasia 60 alveolar rhabdomyosarcoma 60 breast cancer subtypes 60 diagnosed prenatally 60 TMEM#B 60 neuropsychological deficits 60 bone scintigraphy 60 pancreatic neuroendocrine tumors 60 ovarian malignancy 60 CHEK2 60 genotypic resistance 60 metabolic syndrome MetS 60 shorter telomeres 60 nondiabetic 60 neovascular 60 BRCA carriers 60 pituitary adenomas 60 malignant brain 60 causative mutation 60 promoter hypermethylation 60 APOL1 60 neuro degenerative disease 60 prefrontal regions 60 severe periodontitis 60 bladder cancers 60 Genetic mutations 60 TRAF1 C5 60 susceptibility genes 60 carcinomatosis 60 colorectal adenomas 60 cerebral infarction 60 GSTP1 60 non aspirin NSAIDs 60 allogeneic HSCT 60 anterior uveitis 60 electrophysiologic 60 schizophreniform disorder 60 pathologic fractures 60 affective disorders 60 AML MDS 60 causative mutations 60 BRAF V#E 60 genital ulcer disease 60 inherited predisposition 60 pathogenetic mechanisms 60 Gorlin syndrome 60 nerve degeneration 60 immunopathology 60 neuroendocrine cancers 60 postoperative complication 60 mice genetically altered 60 mechanistic studies 60 spontaneous regression 60 metastatic gastric 60 myeloproliferative neoplasms 60 M. pneumoniae 60 acetabular dysplasia 60 lymph node enlargement 60 biochemical imbalance 60 virulence genes 60 neurodevelopmental outcomes 60 comorbid psychiatric 60 multivariable adjusted 60 Parkinsonian 60 Cholangiocarcinoma 60 vasogenic edema 60 post transplant lymphoproliferative 60 rifamycins 60 #p#.# [002] 60 genetic syndromes 60 Vertebral compression fractures 60 anthracycline chemotherapy 60 fructose intolerance 60 recurrent VTE 60 lymphangioleiomyomatosis LAM 60 neuropsychiatric disorder 60 supratentorial 60 HPV subtypes 60 perfusion abnormalities 60 allergic eczema 60 cryptogenic stroke 60 levodopa induced 60 TEAEs 60 Adjuvant chemotherapy 60 Heritability 60 amnestic MCI 60 abacavir Ziagen 60 thyroid nodules 60 Barrett esophagus BE 60 de novo AML 60 SIBO 60 Uterine cancer 60 AAT deficiency 60 microRNA expression 60 Hutchinson Gilford progeria 60 dopamine receptor gene 60 genomic variants 60 Henoch purpura 60 bacteraemia 60 TP# mutations 60 recurrent miscarriages 60 paraneoplastic 60 NPY gene 60 multivariable analysis 60 thrombo embolic 60 CA MRSA infections 60 varicocele 60 bronchoalveolar 60 carcinoid tumors 60 glutamic acid decarboxylase 60 pyelonephritis 60 neuroimaging studies 60 dexrazoxane 60 sonographic diagnosis 60 gadolinium enhanced 60 NMIBC 60 recurrent tonsillitis 60 nephritis 60 CETP gene 60 paricalcitol 60 lacunar 60 neuro degenerative disorder 60 gross hematuria 60 nonalcoholic steatohepatitis 60 enterocolitis 60 S. aureus isolates 60 artery calcification 60 nondiabetic patients 60 TTR amyloidosis 60 MELAS 60 anticholinergic drugs 60 NMDA receptor antagonists 60 pheochromocytoma 60 herpes zoster vaccine 60 CYP#D# gene 60 immunodeficiencies 60 hyperalgesia 60 asthma rhinitis 60 serologic tests 60 ductal cancer 60 colonic mucosa 60 intractable epilepsy 60 histopathologic examination 59 tic disorders 59 EEG recordings 59 diagnose coronary artery 59 MC4R gene 59 neurocognitive impairments 59 precursor lesions 59 osteopenic 59 EGFR blockers 59 Chlamydia infection 59 dizygotic twins 59 glucose abnormalities 59 chronic periodontitis 59 idiopathic pulmonary 59 isolated systolic hypertension 59 ALK mutations 59 choroidal neovascularization 59 etiologic agent 59 fibrate drugs 59 #q# deletion syndrome 59 thrombotic complications 59 primary hyperparathyroidism 59 Chronic myeloid leukemia 59 BRCA deficient 59 retinal vascular 59 LRAT 59 atopic asthma 59 experimentally induced 59 abnormal glucose tolerance 59 related maculopathy 59 SOD1 gene 59 multi infarct dementia 59 lactose malabsorption 59 pathophysiologic mechanism 59 rebleeding 59 nongenetic 59 nociceptive pain 59 gonococcal infection 59 developmental abnormalities 59 rheumatic disease 59 neurodegenerative disorder 59 Irritable Bowel Syndrome IBS 59 asymptomatic PAD 59 immunodeficient 59 lysosomal storage disease 59 TMJ disorders 59 bronchodilatory 59 Diabetic neuropathy 59 bicuspid aortic valves 59 neuronal dysfunction 59 allergic sensitization 59 renal toxicity 59 carcinoid tumor 59 C1 INH deficiency 59 circulating endothelial cells 59 gefitinib Iressa 59 nonvertebral fractures 59 slow metabolizers 59 HLA DQ2 59 SNP rs# [001] 59 thermogram 59 HER2 overexpression 59 postnatally 59 methylation markers 59 Mitochondrial dysfunction 59 GABRA2 59 thyroid abnormalities 59 dysmenorrhoea 59 acute leukemias 59 benign moles 59 Epstein Barr virus EBV 59 PTEN gene 59 toxoplasma 59 macrovascular disease 59 cisplatin resistant 59 obstructive sleep 59 myocardial fibrosis 59 amenorrhoea 59 atopic diseases 59 Osteogenesis imperfecta 59 Hodgkin lymphoma HL 59 transfusion syndrome 59 thyrotropin 59 alpha synuclein gene 59 abnormal proteins 59 knee OA 59 pathophysiologic 59 Testosterone deficiency 59 PIK3CA 59 decompensated cirrhosis 59 pCR 59 phthalate syndrome 59 apo E 59 muscular dystrophy cystic fibrosis 59 genital tract infections 59 metabolic abnormality 59 p# activation 59 prostate cancer PCa 59 elevated homocysteine 59 Kufs disease 59 variant alleles 59 COX inhibitors 59 tarenflurbil 59 homozygote 59 gastric cardia 59 Opportunistic infections 59 oral thrush 59 polyp recurrence 59 TYMS 59 karyotypes 59 coronary blockages 59 myeloproliferative disorders 59 familial hypercholesterolemia FH 59 colorectal carcinoma 59 atypical hemolytic uremic syndrome 59 metastatic lymph nodes 59 SLC#A# [002] 59 arterial thickening 59 HG PIN 59 TNF blocker therapy 59 hepatorenal syndrome 59 tau protein tangles 59 serum PTH 59 orthologous genes 59 myocardial infarctions MI 59 intravenous bisphosphonates 59 hematological relapse 59 neuroregenerative 59 genes predisposing 59 2D 4D ratio 59 hypoperfusion 59 genetic polymorphism 59 Fragile X gene 59 histological subtype 59 abnormalities 59 serum selenium 59 neuron degeneration 59 perioperative complications 59 clinically asymptomatic 59 CNTNAP2 59 modifier genes 59 ischemic lesions 59 multiple sclerosis lupus 59 vascular cognitive impairment 59 hypertension diabetes mellitus 59 frontotemporal dementia 59 clinico pathological 59 neuropsychological impairment 59 pathogenetic 59 pulmonary hypertension PH 59 Severe Primary IGFD 59 elevated ALT 59 fetal chromosomal 59 pharmacologic intervention 59 hereditary deafness 59 interstitial pneumonia 59 gait disturbances 59 thyroid hormone levels 59 tau pathology 59 nonmalignant 59 Endometrial cancer 59 SIDS infants 59 diabetic polyneuropathy 59 acute rhinosinusitis 59 pretransplant 59 histologically proven 59 fibrocytes 59 gene variants 59 glial tumors 59 bowel polyps 59 microvascular disease 59 enteroviral 59 #F FDG PET 59 Immunohistochemical analysis 59 familial hypercholesterolemia 59 aneurysmal subarachnoid hemorrhage 59 airway remodeling 59 chronic renal insufficiency 59 neuroinflammation 59 metastatic lung cancer 59 auditory neuropathy 59 mammary cancers 59 ABCB1 gene 59 computerized tomography scans 59 bile duct obstruction 59 circadian genes 59 undiagnosed celiac disease 59 ASCUS 59 APOE allele 59 cerebrospinal fluid CSF 59 dysglycemia 59 T1c 59 androgen receptor gene 59 ductal carcinomas 59 clade B 59 filaggrin mutations 59 hemodynamic responses 59 cisplatin chemotherapy 59 epithelial tumors 59 hyperintense lesions 59 childhood acute lymphoblastic 59 myeloproliferative diseases 59 AChE inhibitors 59 chromosome rearrangements 59 ApoE4 allele 59 predisposing factors 59 alpha thalassemia 59 leukemias lymphomas 59 recurrent acute pancreatitis 59 klotho gene 59 Squamous cell carcinomas 59 bile acid metabolism 59 multisystem disease 59 T2 lesions